Home > Insider Trading > Filing (0001144204-14-066837)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1369868	China Biologic Products Inc.	CBPO	Biological Products, (No Disgnostic Substances) (2836)	752308816

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1432657	Sean Shao	21St Floor, Everbright Bank Building Zhuzilin, Futian District Shenzhen, Guangdong F4 100125		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2014-11-10	40,000	$12.26	62,500	No	4	M	Direct
Common Stock	Acquisiton	2014-11-10	30,000	$16.39	92,500	No	4	M	Direct
Common Stock	Disposition	2014-11-10	40,000	$62.75	52,500	No	4	S	Direct
Common Stock	Disposition	2014-11-10	30,000	$62.75	22,500	No	4	S	Direct
Common Stock	Disposition	2014-11-10	2,500	$62.75	20,000	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (right to buy)	Disposition	2014-11-10	40,000	$0.00	40,000	$12.26
Common Stock	Stock Option (right to buy)	Disposition	2014-11-10	30,000	$0.00	30,000	$16.39

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
30,000	2010-10-11	2020-07-11	No	4	M	Direct
0	2011-04-01	2021-01-01	No	4	M	Direct

Footnotes

Represents an aggregate of 70,000 shares of common stock (the "Sold Common Stock") sold on the open market for $62.75 per share on November 10, 2014. The Sold Common Stock was acquired by the Reporting Person through the exercise of stock options to purchase the Issuer's common stock. See Footnotes 2 and 3 below for further details on the relevant stock options.
Represents previously reported stock options to purchase 40,000 shares of the Issuer's common stock, granted to the Reporting Person under the Issuer's equity incentive plan, pursuant to a stock option agreement, dated July 11, 2010. The options will vest in equal portions on a quarterly basis over a 3-year period, with the first portion to vest on October 11, 2010.
Represents previously reported stock options to purchase 30,000 shares of the Issuer's common stock, granted to the Reporting Person under the Issuer's equity incentive plan, pursuant to a stock option agreement, dated January 1, 2011. The options will vest in equal portions on a quarterly basis over a 12-month period, with the first portion to vest on April 1, 2011.